We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Withdraws Rule Proposing Public Disclosure of IND Data from Gene Therapies
FDA Withdraws Rule Proposing Public Disclosure of IND Data from Gene Therapies
The FDA withdrew a rule proposed in 2001 that would have required the public disclosure of certain data related to unapproved human gene therapy or the transplantation of non-human tissues to humans from companies seeking approval of investigational new drugs.